Biopharma News

Mar 29, 2018
By BioPharm International Editors
The companies will co-develop and co-promote a CAR T cell therapy in the United States.
Mar 28, 2018
By BioPharm International Editors
Takeda is considering approaching Shire with a possible offer.
Mar 27, 2018
By BioPharm International Editors
In a $13-billion transaction, GSK will purchase Novartis’ share of the Consumer Healthcare Joint Venture.
Mar 26, 2018
By BioPharm International Editors
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
Mar 23, 2018
By BioPharm International Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 21, 2018
By BioPharm International Editors
AbbVie and the International Myeloma Foundation will partner to study the role of a genetic mutation in outcomes of patients with multiple myeloma.
Mar 19, 2018
By BioPharm International Editors
Biogen will acquire an AMPA receptor potentiator for cognitive impairment associated with schizophrenia in a deal worth approximately $590 million.
Mar 19, 2018
By BioPharm International Editors
The companies intend to jointly develop and commercialize Lenvima (lenvatinib mesylate) as a monotherapy and an in-combination therapy for treating multiple cancer types.
Mar 13, 2018
By BioPharm International Editors
The $11.6-billion acquisition strengthens Sanofi's position in hematology and specialty medicines.
Mar 09, 2018
By BioPharm International Editors
The European Medicines Agency has called for the immediate suspension and recall of AbbVie and Biogen's multiple sclerosis drug Zinbryta (daclizumab beta).
native1_300x100
lorem ipsum